Article
The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy.
International journal of molecular sciences - 21 Aug 2021
Costa-Roger Mar, Blasco-Pérez Laura, Cuscó Ivon, Tizzano Eduardo F
Abstract excerpt
After 26 years of discovery of the determinant survival motor neuron 1 and the modifier survival motor neuron 2 genes (SMN1 and SMN2, respectively), three SMN-dependent specific therapies are already approved by FDA and EMA and, as a consequence, worldwide SMA patients are currently under clinical investigation and treatment. Bi-allelic pathogenic variants (mostly deletions) in SMN1 should be detected in SMA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
